 |
0 Diseases |  |
28 Trials |
|
28 Trials |  |
211 News |  |
| «12345 |
- | Modufolin (arfolitixorin) / Isofol Medical, Solasia
New P1/2 trial: PK/PD Investigation of Modufolin (Arfolitixorin) in Plasma, Tumor and Adjacent Mucosa Adjacent Mucosa in Patients With Colon Cancer (clinicaltrials.gov) - Sep 6, 2012
P1/2, N=32, Completed, Sponsor: Isofol Medical AB
- | tivantinib (ARQ 197) / Daiichi Sankyo, Kyowa Kirin, Merck (MSD)
New P1/2 trial, Combination therapy, Metastases: Phase I/II Trial of Tivantinib With FOLFOX for the Treatment of Advanced Solid Tumors and Previously Untreated Metastatic Adenocarcinoma of the Distal Esophagus, Gastroesophageal Junction or Stomach (clinicaltrials.gov) - Jun 3, 2012
P1/2, N=50, Active, not recruiting, Sponsor: SCRI Development Innovations, LLC
- Cyramza (ramucirumab) / Eli Lilly
Trial completion, Combination therapy, Metastases: A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B) (clinicaltrials.gov) - Apr 4, 2012
P1, N=6, Completed, Sponsor: Eli Lilly and Company
Active, not recruiting --> Completed